Keating Investment Counselors Inc Johnson & Johnson Transaction History

Keating Investment Counselors Inc

$230 Million
Q2 2024

A detailed history of Keating Investment Counselors Inc transactions in Johnson & Johnson stock. As of the latest transaction made, Keating Investment Counselors Inc holds 16,099 shares of JNJ stock, worth $2.65 Million. This represents 1.02% of its overall portfolio holdings.

Number of Shares

16,099

Previous 16,491 2.38%

Holding current value

$2.65 Million

Previous $2.61 Million 9.78%

% of portfolio

1.02%

Previous 1.08%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 06, 2024	SELL	$144.38 - $157.78 $56,596 - $61,849	-392 Reduced 2.38%	16,099 $2.35 Million
Q1 2024 May 07, 2024	SELL	$155.22 - $162.74 $1.08 Million - $1.13 Million	-6,934 Reduced 29.6%	16,491 $2.61 Million
Q4 2023 Feb 07, 2024	SELL	$145.6 - $158.88 $78,478 - $85,636	-539 Reduced 2.25%	23,425 $3.67 Million
Q3 2023 Oct 25, 2023	SELL	$155.75 - $174.48 $140,953 - $157,904	-905 Reduced 3.64%	23,964 $3.73 Million
Q2 2023 Aug 02, 2023	SELL	$154.35 - $166.11 $267,025 - $287,370	-1,730 Reduced 6.5%	24,869 $4.12 Million
Q1 2023 May 04, 2023	SELL	$151.05 - $180.26 $262,071 - $312,751	-1,735 Reduced 6.12%	26,599 $4.12 Million
Q4 2022 Feb 08, 2023	BUY	$160.2 - $179.79 $942,937 - $1.06 Million	5,886 Added 26.22%	28,334 $5.01 Million
Q3 2022 Nov 03, 2022	SELL	$161.33 - $179.52 $876,828 - $975,691	-5,435 Reduced 19.49%	22,448 $3.67 Million
Q2 2022 Aug 03, 2022	SELL	$168.19 - $186.01 $507,933 - $561,750	-3,020 Reduced 9.77%	27,883 $4.95 Million
Q1 2022 Apr 28, 2022	SELL	$158.14 - $179.59 $128,251 - $145,647	-811 Reduced 2.56%	30,903 $5.48 Million
Q4 2021 Jan 26, 2022	SELL	$155.93 - $173.01 $79,056 - $87,716	-507 Reduced 1.57%	31,714 $5.43 Million
Q3 2021 Oct 27, 2021	SELL	$161.5 - $179.47 $58,140 - $64,609	-360 Reduced 1.1%	32,221 $5.2 Million
Q2 2021 Jul 29, 2021	SELL	$159.48 - $171.07 $325,339 - $348,982	-2,040 Reduced 5.89%	32,581 $5.37 Million
Q1 2021 Apr 26, 2021	SELL	$153.07 - $170.48 $264,811 - $294,930	-1,730 Reduced 4.76%	34,621 $5.69 Million
Q4 2020 Jan 27, 2021	SELL	$137.11 - $157.38 $27,422 - $31,476	-200 Reduced 0.55%	36,351 $5.72 Million
Q3 2020 Oct 23, 2020	SELL	$140.38 - $153.83 $126,342 - $138,447	-900 Reduced 2.4%	36,551 $5.44 Million
Q2 2020 Jul 22, 2020	SELL	$128.81 - $155.51 $219,621 - $265,144	-1,705 Reduced 4.35%	37,451 $5.27 Million
Q1 2020 Apr 29, 2020	SELL	$111.14 - $153.99 $302,078 - $418,544	-2,718 Reduced 6.49%	39,156 $5.14 Million
Q4 2019 Jan 28, 2020	SELL	$127.5 - $146.44 $117,937 - $135,457	-925 Reduced 2.16%	41,874 $6.11 Million
Q3 2019 Oct 28, 2019	SELL	$126.95 - $142.14 $342,130 - $383,067	-2,695 Reduced 5.92%	42,799 $5.54 Million
Q2 2019 Aug 01, 2019	SELL	$131.15 - $144.24 $1.65 Million - $1.81 Million	-12,568 Reduced 21.65%	45,494 $6.34 Million
Q1 2019 Apr 22, 2019	SELL	$125.72 - $139.79 $184,808 - $205,491	-1,470 Reduced 2.47%	58,062 $8.12 Million
Q4 2018 Feb 12, 2019	SELL	$122.84 - $147.84 $171,607 - $206,532	-1,397 Reduced 2.29%	59,532 $7.68 Million
Q3 2018 Oct 30, 2018	SELL	$121.58 - $142.88 $826,257 - $971,012	-6,796 Reduced 10.03%	60,929 $8.42 Million
Q2 2018 Aug 01, 2018	SELL	$119.4 - $131.76 $102,684 - $113,313	-860 Reduced 1.25%	67,725 $8.22 Million
Q1 2018 May 11, 2018	SELL	$125.1 - $148.14 $414,206 - $490,491	-3,311 Reduced 4.61%	68,585 $8.79 Million
Q4 2017 Feb 14, 2018	SELL	$131.22 - $143.62 $105,632 - $115,614	-805 Reduced 1.11%	71,896 $10 Million
Q3 2017 Nov 09, 2017	SELL	$129.47 - $135.38 $84,155 - $87,997	-650 Reduced 0.89%	72,701 $9.45 Million
Q2 2017 Aug 10, 2017	BUY	N/A	73,351	73,351 $9.7 Million

Others Institutions Holding JNJ

# of Institutions

4,157

Shares Held

1.69B

Call Options Held

12.5M

Put Options Held

10.3M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $430B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Keating Investment Counselors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Keating Investment Counselors Inc with notifications on news.

Account

Keating Investment Counselors Inc Johnson & Johnson Transaction History